Brian Low Financial Group’s AstraZeneca AZN Stock Holding History

Brian Low Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Buy	10,712 +1,550	+17%	+$292K	1.18%	23
2026 Q1	$1.81M	Buy	9,162 +715	+8%	+$138K	1.23%	21
2025 Q4	$1.55M	Sell	8,447 -418	-5%	-$73.3K	1.1%	24
2025 Q3	$1.36M	Buy	8,865 +1,981	+29%	+$300K	1.06%	20
2025 Q2	$962K	Buy	+6,884	New	+$965K	0.9%	27

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brian Low Financial Group's AZN Position: Q2 2026 in Review

Brian Low Financial Group increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $292K and bringing the position to 10,712 shares worth $2.03M. The position accounts for 1.18% of the portfolio, ranked #23.

Brian Low Financial Group first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Brian Low Financial Group held 10,712 shares of AstraZeneca worth $2.03M as of Q2 2026.
Brian Low Financial Group bought 1,550 AstraZeneca shares in Q2 2026, an estimated $292K.
AstraZeneca made up 1.18% of Brian Low Financial Group's portfolio in Q2 2026, its #23 holding.
Brian Low Financial Group first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Brian Low Financial Group's 13F filing for Q2 2026, filed 28 Jul 2026.